DeLisa's work highlighted in a Nature technology feature

“Cell-free systems turn protein synthesis into more of a chemistry problem than a biology problem.”

A recent technology feature in the journal Nature highlighted the work of CBE Professor Matt DeLisa, the William L. Lewis Professor of Engineering and Director of the Cornell Institute of Biotechnology. The story, “How cell-free processes could speed up vaccine development,” discusses the ongoing efforts of bioengineers, including DeLisa and his team, to discover cheaper and easier ways to make proteins and other complex biomolecules. Antibodies, for instance, have become the bread and butter for many pharmaceutical companies, and DeLisa says that the ability to synthesize these molecules using cost-effective cell-free methods would be a “game changer”. 


Other Articles of Interest